Table 6.
Fecal SCFAs of participants at baseline and after 4 weeks of the YS, PRE, POST, or CAPSULE treatment perioda,b
| Variables | BL (n = 30) |
YS (n = 25) |
PRE (n = 25) |
POST (n = 26) |
CAP (n = 26) |
P-value* |
|---|---|---|---|---|---|---|
| Total SCFAs, μg/g | 2533 ± 208 | 2818 ± 219 | 2823 ± 216 | 2517 ± 220 | 2654 ± 219 | 0.66 |
| Acetate, μg/g | 701 ± 68 | 914 ± 71** | 900 ± 70** | 773 ± 71 | 780 ± 71 | 0.05 |
| Propionate, μg/g | 527 ± 47 | 633 ± 50 | 602 ± 49 | 529 ± 50 | 560 ± 50 | 0.32 |
| Butyrate, μg/g | 798 ± 86 | 889 ± 91 | 921 ± 90 | 755 ± 91 | 865 ± 91 | 0.55 |
aValues are means ± SEMs; BL, baseline; YS, yogurt smoothie with no BB-12®; PRE, yogurt smoothie with BB-12® added pre-fermentation; POST, yogurt smoothie with BB-12® post-fermentation; SCFAs, short chain fatty acids
bStatistical analyses were calculated using sex, treatment as between subject factor and randomization ID as the within-subject factor and age, BMI, fiber intake as covariates
*P values are for the main effect of treatment
** Values are significantly difference from baseline (P < 0.01)